Comparing the current results to its competitors, Nanostring Technologies Inc reported Revenue increase in the 3 quarter 2023 by 62.79 % year on year, while most of its competitors have experienced contraction in revenues by -2.2 %, achieved in the same quarter.
Due to outstanding performance in Overall company, revenue grew by 62.79 % Nanostring Technologies Inc improved its market share, to approximately 0.33 %.
January 7, 2024
Combining the Power of NanoStrings CosMx SMI: Achieving Whole Transcriptome Imaging at Single-Cell ResolutionSeamlessly fusing cutting-edge technology with the realm of life sciences, NanoString Technologies Inc. (NASDAQ: NSTG) has unveiled a groundbreaking achievement in research tools the first public dataset of the whole transcriptome obtained at true single-cell resolution on the CosMx Spatial Molecular Imager (SMI). This monumental leap in spatial transcriptomics offers unprecedented insights into the inner workings of cells and promises to revolutionize discovery and translational research.NanoString Technologies, recognized as a front-runner in providing advanced life science tools, will unveil the ...
Publicly Traded Peers of Nanostring Technologies Inc
Qiagen N v Share Performance
-2.05%
Over The Past 5 Days
Qiagen N v
Profile
Qiagen N.V. is a Dutch multinational company that operates in the field of molecular diagnostics and sample preparation technologies. Their business model revolves around developing and manufacturing products and solutions for molecular testing, enabling researchers and healthcare professionals to analyze biological samples and gain insights into diseases and genetic variations. Qiagen N.V. primarily generates revenue through the sale of instruments, consumables, and related services to customers in various market segments including academia, pharmaceuticals, and diagnostics.
Bio-Techne Corp operates as a global life sciences company that provides innovative tools and solutions. They offer a diverse portfolio of products, including research reagents, diagnostic controls, and protein analysis tools, catering to the needs of academia, pharmaceutical and biotechnology companies. The company focuses on driving scientific advancements and aiding researchers in understanding biological systems by developing cutting-edge technologies and delivering high-quality products and services.
Repligen Corp operates as a bioprocessing company that provides products and services to the life sciences industry. They focus on the development, production, and distribution of highly specialized consumable products used in the manufacture of biological drugs. Repligen's business model revolves around helping their customers enhance productivity, improve quality, and reduce production costs in the biopharmaceutical manufacturing process.
Illumina Inc is a leading company in the genomics sector, focusing on next-generation sequencing technologies that enhance genetic analysis. Their business model encompasses a diverse range of products, including sequencing platforms, reagents, and bioinformatics solutions, which together facilitate comprehensive genomic studies for researchers. By integrating these tools, Illumina supports advancements in fields such as oncology, drug discovery, and personalized healthcare, positioning itself at the forefront of genomic innovation.
Bio-Rad Laboratories Inc operates as a global leader in life sciences and clinical diagnostics by focusing on the development, manufacturing, and distribution of a diverse array of products and solutions. Their business model emphasizes innovation, providing advanced tools and technologies that empower scientists and healthcare professionals to effectively analyze biological materials. By delivering high-quality solutions, Bio-Rad aims to facilitate scientific breakthroughs and enhance patient care in various healthcare settings.
Sources:
Nanostring Technologies Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Nanostring Technologies Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.
Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.
